Measures to curb Malpractices in Pharma Companies

• UCPMP 2024 = government-notified code regulating how pharma firms market drugs to doctors / Registered Medical Practitioners (RMPs) to prevent unethical inducements.
• Notified by Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, on 12 March 2024.
• Topical for GS-II (governance/health) & GS-IV (ethics in private sector, conflict of interest) — links to drug pricing, medical ethics, consumer protection.